Who owns Tenax Therapeutics?
- CUSIP Number: 88032l506
Tip: Access positions for across all investors
Analyze quarterly positions in Tenax Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tenax Therapeutics stock
Who bought or sold Tenax Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| CI Private Wealth | 191k | $52k | 0% | Dec 2023 |
|
| Vanguard Group | 186k | $51k | 100% | Dec 2023 |
|
| Two Sigma Investments | 142k | $39k | 100% | Dec 2023 |
|
| Citadel Advisors | 51k | $14k | 236% | Dec 2023 |
|
| Hrt Financial | 21k | $5.0k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 184.00 | $51.004800 | 15% | Dec 2023 |
|
| Tucker Asset Management | 2.00 | $1.000000 | 0% | Dec 2023 |
|
Who sold out of Tenax Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Sep 2023 | 97k | $29k |
| Virtu Financial | Sep 2023 | 37k | $11k |
| Honkamp Krueger Financial Services | Sep 2023 | 10k | $3.0k |
| Lido Advisors | Sep 2023 | 10k | $3.0k |
| Banque Cantonale Vaudoise | Dec 2023 | 50.00 | $0 |